Research at University Health Network
 
Technology Transfer
Menu Level 3  
 
   
Technology Transfer

Technology Development & Commercialization News Archives

30.11.2011 - UHN has signed a non-exclusive licensing agreement with Edwards Lifesciences regarding stand-alone and web-based simulations developed by the Perioperative Interactive Education (PIE) team in the Department of Anesthesia and Pain Management at the Toronto General Hospital. Read more...
26.10.2011 - UHN has signed a follow-on licensing agreement with Vexim SA, regarding a deformable template registration and segmentation technology developed by UHN's Joint Department of Medical Imaging. Read more...

7.03.2011 - RaySearch Laboratories AB (publ.) has entered into an exclusive license agreement with Princess Margaret Hospital (PMH) in Toronto, Canada regarding deformable image registration technology.  RaySearch and PMH have a long-standing research collaboration focused on strategies and tools for adaptive radiation therapy.  Read more...

27.10.2010 - International Malaria Research Consortium Combines Technologies and
Expertise From Two Continents to Tackle Deadly Disease.  Read more...
13.06.2010 - UHN Drug Discovery licensed to APEIRON Biologics to be developed by GlaxoSmithKline.  Read more...
25.05.2010 -  UHN Joins iBridge to Highlight Latest Biomedical Licensing Opportunities as iBridge’s First Canadian Partner.  Read more... http://www.ibridgenetwork.org/images/logo.gif
21.04.2010 - UHN and UHN’s Technology Development and Commercialization office were delighted to present Dr. Mohammad Islam and Dr. Michael Sharpe with UHN’s Inventor of the Year award for 2009.  This award, presented at the recent Board of Trustees retreat on April 21st.  Read more...

11.04.2010 - UHN - Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs. Read more...

30.11.2009 - Over the last four years a team of scientists at the Princess Margaret Hospital have developed, in partnership with Precision X-Ray Inc, the first commercially produced small animal Image Guided X-Ray Irradiation System, the X-RAD 225Cx.  Read more...
14.10.2009 - TDC recently negotiated an exclusive license and collaboration agreement with the Vancouver biotechnology company MedBioGene Inc. to further develop this ground-breaking prognostic genomic analysis for early stage non-small cell lung cancer. Read more...
16.09.2009 - Release of the 2009 UHN Technology Licensing Opportunities

15.07.2009 - UHN, OICR and Pfizer Colorectal Cancer Collaboration. Read more...

16.06.2009 - TDC would like to announce the release of the TDC-UHN Inaugural Research Commercialization report. To view the report click here.

19.01.2008 - Michelson Diagnostics signs license agreement with UHN.  Read more...

04.04.2006 - Amorfix Life Sciences in-Licenses second novel technology to strengthen its ALS therapeutic program.  Read more...

 

 

 

   
 
 
 
Home Researchers Facilities Support Services Programs Commercialization Ethics News About UHN Institutes OCI Techna TGRI TRI TWRI